Product References
FK506-Binding Protein like (FKBPL) Has an Important Role in Heart Failure with Preserved Ejection Fraction Pathogenesis with Potential Diagnostic Utility.
Biomolecules
Chhor M,Chen H,Jerotić D,Tešić M,Nikolić VN,Pavlović M,Vučić RM,Rayner B,Watson CJ,Ledwidge M,McDonald K,Robson T,McGrath KC,McClements L
Sat Feb 18 00:00:00 EST 2023
E-Cigarette Aerosol Condensate Leads to Impaired Coronary Endothelial Cell Health and Restricted Angiogenesis.
International journal of molecular sciences
Chhor M,Tulpar E,Nguyen T,Cranfield CG,Gorrie CA,Chan YL,Chen H,Oliver BG,McClements L,McGrath KC
Tue Mar 28 00:00:00 EDT 2023
A placenta-on-a-chip model to determine the regulation of FKBPL and galectin-3 in preeclampsia.
Cellular and molecular life sciences : CMLS
Ghorbanpour SM,Richards C,Pienaar D,Sesperez K,Aboulkheyr Es H,Nikolic VN,Karadzov Orlic N,Mikovic Z,Stefanovic M,Cakic Z,Alqudah A,Cole L,Gorrie C,McGrath K,Kavurma MM,Ebrahimi Warkiani M,McClements L
Wed Jan 18 00:00:00 EST 2023
Loss of Expression of Antiangiogenic Protein FKBPL in Endometrioid Endometrial Carcinoma: Implications for Clinical Practice.
Medicina (Kaunas, Lithuania)
Obradović DD,Milić NM,Miladinović N,McClements L,Oprić DM
Thu Sep 22 00:00:00 EDT 2022
FKBPL and SIRT-1 Are Downregulated by Diabetes in Pregnancy Impacting on Angiogenesis and Endothelial Function.
Frontiers in endocrinology
Alqudah A,Eastwood KA,Jerotic D,Todd N,Hoch D,McNally R,Obradovic D,Dugalic S,Hunter AJ,Holmes VA,McCance DR,Young IS,Watson CJ,Robson T,Desoye G,Grieve DJ,McClements L
Fri Jan 07 00:00:00 EST 2022
FKBPL and SIRT-1 Are Downregulated by Diabetes in Pregnancy Impacting on Angiogenesis and Endothelial Function.
Frontiers in endocrinology
Alqudah A,Eastwood KA,Jerotic D,Todd N,Hoch D,McNally R,Obradovic D,Dugalic S,Hunter AJ,Holmes VA,McCance DR,Young IS,Watson CJ,Robson T,Desoye G,Grieve DJ,McClements L
Fri Jan 07 00:00:00 EST 2022
Characterisation of cardiac health in the reduced uterine perfusion pressure model and a 3D cardiac spheroid model, of preeclampsia.
Biology of sex differences
Richards C,Sesperez K,Chhor M,Ghorbanpour S,Rennie C,Ming CLC,Evenhuis C,Nikolic V,Orlic NK,Mikovic Z,Stefanovic M,Cakic Z,McGrath K,Gentile C,Bubb K,McClements L
Tue Apr 20 00:00:00 EDT 2021
Characterisation of cardiac health in the reduced uterine perfusion pressure model and a 3D cardiac spheroid model, of preeclampsia.
Biology of sex differences
Richards C,Sesperez K,Chhor M,Ghorbanpour S,Rennie C,Ming CLC,Evenhuis C,Nikolic V,Orlic NK,Mikovic Z,Stefanovic M,Cakic Z,McGrath K,Gentile C,Bubb K,McClements L
Tue Apr 20 00:00:00 EDT 2021
Characterisation of cardiac health in the reduced uterine perfusion pressure model and a 3D cardiac spheroid model, of preeclampsia.
Biology of sex differences
Richards C,Sesperez K,Chhor M,Ghorbanpour S,Rennie C,Ming CLC,Evenhuis C,Nikolic V,Orlic NK,Mikovic Z,Stefanovic M,Cakic Z,McGrath K,Gentile C,Bubb K,McClements L
Tue Apr 20 00:00:00 EDT 2021
Characterisation of cardiac health in the reduced uterine perfusion pressure model and a 3D cardiac spheroid model, of preeclampsia.
Biology of sex differences
Richards C,Sesperez K,Chhor M,Ghorbanpour S,Rennie C,Ming CLC,Evenhuis C,Nikolic V,Orlic NK,Mikovic Z,Stefanovic M,Cakic Z,McGrath K,Gentile C,Bubb K,McClements L
Tue Apr 20 00:00:00 EDT 2021
Role of A Novel Angiogenesis FKBPL-CD44 Pathway in Preeclampsia Risk Stratification and Mesenchymal Stem Cell Treatment.
The Journal of clinical endocrinology and metabolism
Todd N,McNally R,Alqudah A,Jerotic D,Suvakov S,Obradovic D,Hoch D,Hombrebueno JR,Campos GL,Watson CJ,Gojnic-Dugalic M,Simic TP,Krasnodembskaya A,Desoye G,Eastwood KA,Hunter AJ,Holmes VA,McCance DR,Young IS,Grieve DJ,Kenny LC,Garovic VD,Robson T,McClements L
Fri Jan 01 00:00:00 EST 2021
Role of A Novel Angiogenesis FKBPL-CD44 Pathway in Preeclampsia Risk Stratification and Mesenchymal Stem Cell Treatment.
The Journal of clinical endocrinology and metabolism
Todd N,McNally R,Alqudah A,Jerotic D,Suvakov S,Obradovic D,Hoch D,Hombrebueno JR,Campos GL,Watson CJ,Gojnic-Dugalic M,Simic TP,Krasnodembskaya A,Desoye G,Eastwood KA,Hunter AJ,Holmes VA,McCance DR,Young IS,Grieve DJ,Kenny LC,Garovic VD,Robson T,McClements L
Fri Jan 01 00:00:00 EST 2021
FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4.
BMC cancer
McClements L,Annett S,Yakkundi A,O'Rourke M,Valentine A,Moustafa N,Alqudah A,Simões BM,Furlong F,Short A,McIntosh SA,McCarthy HO,Clarke RB,Robson T
Thu Apr 11 00:00:00 EDT 2019
Delivery of RALA/siFKBPL nanoparticles via electrospun bilayer nanofibres: An innovative angiogenic therapy for wound repair.
Journal of controlled release : official journal of the Controlled Release Society
Mulholland EJ,Ali A,Robson T,Dunne NJ,McCarthy HO
Sat Dec 28 00:00:00 EST 2019
FKBPL is a critical antiangiogenic regulator of developmental and pathological angiogenesis.
Arteriosclerosis, thrombosis, and vascular biology
Yakkundi A,Bennett R,Hernández-Negrete I,Delalande JM,Hanna M,Lyubomska O,Arthur K,Short A,McKeen H,Nelson L,McCrudden CM,McNally R,McClements L,McCarthy HO,Burns AJ,Bicknell R,Kissenpfennig A,Robson T
Wed Apr 01 00:00:00 EDT 2015
FKBPL is a critical antiangiogenic regulator of developmental and pathological angiogenesis.
Arteriosclerosis, thrombosis, and vascular biology
Yakkundi A,Bennett R,Hernández-Negrete I,Delalande JM,Hanna M,Lyubomska O,Arthur K,Short A,McKeen H,Nelson L,McCrudden CM,McNally R,McClements L,McCarthy HO,Burns AJ,Bicknell R,Kissenpfennig A,Robson T
Wed Apr 01 00:00:00 EDT 2015
FKBPL is a critical antiangiogenic regulator of developmental and pathological angiogenesis.
Arteriosclerosis, thrombosis, and vascular biology
Yakkundi A,Bennett R,Hernández-Negrete I,Delalande JM,Hanna M,Lyubomska O,Arthur K,Short A,McKeen H,Nelson L,McCrudden CM,McNally R,McClements L,McCarthy HO,Burns AJ,Bicknell R,Kissenpfennig A,Robson T
Wed Apr 01 00:00:00 EDT 2015
FKBPL is a critical antiangiogenic regulator of developmental and pathological angiogenesis.
Arteriosclerosis, thrombosis, and vascular biology
Yakkundi A,Bennett R,Hernández-Negrete I,Delalande JM,Hanna M,Lyubomska O,Arthur K,Short A,McKeen H,Nelson L,McCrudden CM,McNally R,McClements L,McCarthy HO,Burns AJ,Bicknell R,Kissenpfennig A,Robson T
Wed Apr 01 00:00:00 EDT 2015
RALA-mediated delivery of FKBPL nucleic acid therapeutics.
Nanomedicine (London, England)
Bennett R,Yakkundi A,McKeen HD,McClements L,McKeogh TJ,McCrudden CM,Arthur K,Robson T,McCarthy HO
Thu Oct 01 00:00:00 EDT 2015
RALA-mediated delivery of FKBPL nucleic acid therapeutics.
Nanomedicine (London, England)
Bennett R,Yakkundi A,McKeen HD,McClements L,McKeogh TJ,McCrudden CM,Arthur K,Robson T,McCarthy HO
Thu Oct 01 00:00:00 EDT 2015
RALA-mediated delivery of FKBPL nucleic acid therapeutics.
Nanomedicine (London, England)
Bennett R,Yakkundi A,McKeen HD,McClements L,McKeogh TJ,McCrudden CM,Arthur K,Robson T,McCarthy HO
Thu Oct 01 00:00:00 EDT 2015
RALA-mediated delivery of FKBPL nucleic acid therapeutics.
Nanomedicine (London, England)
Bennett R,Yakkundi A,McKeen HD,McClements L,McKeogh TJ,McCrudden CM,Arthur K,Robson T,McCarthy HO
Thu Oct 01 00:00:00 EDT 2015
FKBPL: a marker of good prognosis in breast cancer.
Oncotarget
Nelson L,McKeen HD,Marshall A,Mulrane L,Starczynski J,Storr SJ,Lanigan F,Byrne C,Arthur K,Hegarty S,Ali AA,Furlong F,McCarthy HO,Ellis IO,Green AR,Rakha E,Young L,Kunkler I,Thomas J,Jack W,Cameron D,Jirström K,Yakkundi A,McClements L,Martin SG,Gallagher WM,Dunn J,Bartlett J,O'Connor D,Robson T
Wed May 20 00:00:00 EDT 2015
FKBPL: a marker of good prognosis in breast cancer.
Oncotarget
Nelson L,McKeen HD,Marshall A,Mulrane L,Starczynski J,Storr SJ,Lanigan F,Byrne C,Arthur K,Hegarty S,Ali AA,Furlong F,McCarthy HO,Ellis IO,Green AR,Rakha E,Young L,Kunkler I,Thomas J,Jack W,Cameron D,Jirström K,Yakkundi A,McClements L,Martin SG,Gallagher WM,Dunn J,Bartlett J,O'Connor D,Robson T
Wed May 20 00:00:00 EDT 2015
FKBPL: a marker of good prognosis in breast cancer.
Oncotarget
Nelson L,McKeen HD,Marshall A,Mulrane L,Starczynski J,Storr SJ,Lanigan F,Byrne C,Arthur K,Hegarty S,Ali AA,Furlong F,McCarthy HO,Ellis IO,Green AR,Rakha E,Young L,Kunkler I,Thomas J,Jack W,Cameron D,Jirström K,Yakkundi A,McClements L,Martin SG,Gallagher WM,Dunn J,Bartlett J,O'Connor D,Robson T
Wed May 20 00:00:00 EDT 2015
FKBPL: a marker of good prognosis in breast cancer.
Oncotarget
Nelson L,McKeen HD,Marshall A,Mulrane L,Starczynski J,Storr SJ,Lanigan F,Byrne C,Arthur K,Hegarty S,Ali AA,Furlong F,McCarthy HO,Ellis IO,Green AR,Rakha E,Young L,Kunkler I,Thomas J,Jack W,Cameron D,Jirström K,Yakkundi A,McClements L,Martin SG,Gallagher WM,Dunn J,Bartlett J,O'Connor D,Robson T
Wed May 20 00:00:00 EDT 2015
Identification of RBCK1 as a novel regulator of FKBPL: implications for tumor growth and response to tamoxifen.
Oncogene
Donley C,McClelland K,McKeen HD,Nelson L,Yakkundi A,Jithesh PV,Burrows J,McClements L,Valentine A,Prise KM,McCarthy HO,Robson T
Thu Jun 26 00:00:00 EDT 2014
Identification of RBCK1 as a novel regulator of FKBPL: implications for tumor growth and response to tamoxifen.
Oncogene
Donley C,McClelland K,McKeen HD,Nelson L,Yakkundi A,Jithesh PV,Burrows J,McClements L,Valentine A,Prise KM,McCarthy HO,Robson T
Thu Jun 26 00:00:00 EDT 2014
Identification of RBCK1 as a novel regulator of FKBPL: implications for tumor growth and response to tamoxifen.
Oncogene
Donley C,McClelland K,McKeen HD,Nelson L,Yakkundi A,Jithesh PV,Burrows J,McClements L,Valentine A,Prise KM,McCarthy HO,Robson T
Thu Jun 26 00:00:00 EDT 2014
Identification of RBCK1 as a novel regulator of FKBPL: implications for tumor growth and response to tamoxifen.
Oncogene
Donley C,McClelland K,McKeen HD,Nelson L,Yakkundi A,Jithesh PV,Burrows J,McClements L,Valentine A,Prise KM,McCarthy HO,Robson T
Thu Jun 26 00:00:00 EDT 2014
The anti-migratory effects of FKBPL and its peptide derivative, AD-01: regulation of CD44 and the cytoskeletal pathway.
PloS one
Yakkundi A,McCallum L,O'Kane A,Dyer H,Worthington J,McKeen HD,McClements L,Elliott C,McCarthy HO,Hirst DG,Robson T
Mon Aug 26 00:00:00 EDT 2013
The anti-migratory effects of FKBPL and its peptide derivative, AD-01: regulation of CD44 and the cytoskeletal pathway.
PloS one
Yakkundi A,McCallum L,O'Kane A,Dyer H,Worthington J,McKeen HD,McClements L,Elliott C,McCarthy HO,Hirst DG,Robson T
Mon Aug 26 00:00:00 EDT 2013
The anti-migratory effects of FKBPL and its peptide derivative, AD-01: regulation of CD44 and the cytoskeletal pathway.
PloS one
Yakkundi A,McCallum L,O'Kane A,Dyer H,Worthington J,McKeen HD,McClements L,Elliott C,McCarthy HO,Hirst DG,Robson T
Mon Aug 26 00:00:00 EDT 2013
The anti-migratory effects of FKBPL and its peptide derivative, AD-01: regulation of CD44 and the cytoskeletal pathway.
PloS one
Yakkundi A,McCallum L,O'Kane A,Dyer H,Worthington J,McKeen HD,McClements L,Elliott C,McCarthy HO,Hirst DG,Robson T
Mon Aug 26 00:00:00 EDT 2013
FKBPL and peptide derivatives: novel biological agents that inhibit angiogenesis by a CD44-dependent mechanism.
Clinical cancer research : an official journal of the American Association for Cancer Research
Valentine A,O'Rourke M,Yakkundi A,Worthington J,Hookham M,Bicknell R,McCarthy HO,McClelland K,McCallum L,Dyer H,McKeen H,Waugh DJ,Roberts J,McGregor J,Cotton G,James I,Harrison T,Hirst DG,Robson T
Tue Mar 01 00:00:00 EST 2011
FKBPL and peptide derivatives: novel biological agents that inhibit angiogenesis by a CD44-dependent mechanism.
Clinical cancer research : an official journal of the American Association for Cancer Research
Valentine A,O'Rourke M,Yakkundi A,Worthington J,Hookham M,Bicknell R,McCarthy HO,McClelland K,McCallum L,Dyer H,McKeen H,Waugh DJ,Roberts J,McGregor J,Cotton G,James I,Harrison T,Hirst DG,Robson T
Tue Mar 01 00:00:00 EST 2011
FKBPL and peptide derivatives: novel biological agents that inhibit angiogenesis by a CD44-dependent mechanism.
Clinical cancer research : an official journal of the American Association for Cancer Research
Valentine A,O'Rourke M,Yakkundi A,Worthington J,Hookham M,Bicknell R,McCarthy HO,McClelland K,McCallum L,Dyer H,McKeen H,Waugh DJ,Roberts J,McGregor J,Cotton G,James I,Harrison T,Hirst DG,Robson T
Tue Mar 01 00:00:00 EST 2011
FKBPL and peptide derivatives: novel biological agents that inhibit angiogenesis by a CD44-dependent mechanism.
Clinical cancer research : an official journal of the American Association for Cancer Research
Valentine A,O'Rourke M,Yakkundi A,Worthington J,Hookham M,Bicknell R,McCarthy HO,McClelland K,McCallum L,Dyer H,McKeen H,Waugh DJ,Roberts J,McGregor J,Cotton G,James I,Harrison T,Hirst DG,Robson T
Tue Mar 01 00:00:00 EST 2011
FKBPL regulates estrogen receptor signaling and determines response to endocrine therapy.
Cancer research
McKeen HD,Byrne C,Jithesh PV,Donley C,Valentine A,Yakkundi A,O'Rourke M,Swanton C,McCarthy HO,Hirst DG,Robson T
Mon Feb 01 00:00:00 EST 2010
FKBPL regulates estrogen receptor signaling and determines response to endocrine therapy.
Cancer research
McKeen HD,Byrne C,Jithesh PV,Donley C,Valentine A,Yakkundi A,O'Rourke M,Swanton C,McCarthy HO,Hirst DG,Robson T
Mon Feb 01 00:00:00 EST 2010
Human GTSE-1 regulates p21(CIP1/WAF1) stability conferring resistance to paclitaxel treatment.
The Journal of biological chemistry
Bublik DR,Scolz M,Triolo G,Monte M,Schneider C
Fri Feb 19 00:00:00 EST 2010
Human GTSE-1 regulates p21(CIP1/WAF1) stability conferring resistance to paclitaxel treatment.
The Journal of biological chemistry
Bublik DR,Scolz M,Triolo G,Monte M,Schneider C
Fri Feb 19 00:00:00 EST 2010
Alterations in the steroid hormone receptor co-chaperone FKBPL are associated with male infertility: a case-control study.
Reproductive biology and endocrinology : RB&E
Sunnotel O,Hiripi L,Lagan K,McDaid JR,De León JM,Miyagawa Y,Crowe H,Kaluskar S,Ward M,Scullion C,Campbell A,Downes CS,Hirst D,Barton D,Mocanu E,Tsujimura A,Cox MB,Robson T,Walsh CP
Mon Mar 08 00:00:00 EST 2010
Alterations in the steroid hormone receptor co-chaperone FKBPL are associated with male infertility: a case-control study.
Reproductive biology and endocrinology : RB&E
Sunnotel O,Hiripi L,Lagan K,McDaid JR,De León JM,Miyagawa Y,Crowe H,Kaluskar S,Ward M,Scullion C,Campbell A,Downes CS,Hirst D,Barton D,Mocanu E,Tsujimura A,Cox MB,Robson T,Walsh CP
Mon Mar 08 00:00:00 EST 2010
Alterations in the steroid hormone receptor co-chaperone FKBPL are associated with male infertility: a case-control study.
Reproductive biology and endocrinology : RB&E
Sunnotel O,Hiripi L,Lagan K,McDaid JR,De León JM,Miyagawa Y,Crowe H,Kaluskar S,Ward M,Scullion C,Campbell A,Downes CS,Hirst D,Barton D,Mocanu E,Tsujimura A,Cox MB,Robson T,Walsh CP
Mon Mar 08 00:00:00 EST 2010
Alterations in the steroid hormone receptor co-chaperone FKBPL are associated with male infertility: a case-control study.
Reproductive biology and endocrinology : RB&E
Sunnotel O,Hiripi L,Lagan K,McDaid JR,De León JM,Miyagawa Y,Crowe H,Kaluskar S,Ward M,Scullion C,Campbell A,Downes CS,Hirst D,Barton D,Mocanu E,Tsujimura A,Cox MB,Robson T,Walsh CP
Mon Mar 08 00:00:00 EST 2010
A novel FK506-like binding protein interacts with the glucocorticoid receptor and regulates steroid receptor signaling.
Endocrinology
McKeen HD,McAlpine K,Valentine A,Quinn DJ,McClelland K,Byrne C,O'Rourke M,Young S,Scott CJ,McCarthy HO,Hirst DG,Robson T
Sat Nov 01 00:00:00 EDT 2008
A novel FK506-like binding protein interacts with the glucocorticoid receptor and regulates steroid receptor signaling.
Endocrinology
McKeen HD,McAlpine K,Valentine A,Quinn DJ,McClelland K,Byrne C,O'Rourke M,Young S,Scott CJ,McCarthy HO,Hirst DG,Robson T
Sat Nov 01 00:00:00 EDT 2008
A novel FK506-like binding protein interacts with the glucocorticoid receptor and regulates steroid receptor signaling.
Endocrinology
McKeen HD,McAlpine K,Valentine A,Quinn DJ,McClelland K,Byrne C,O'Rourke M,Young S,Scott CJ,McCarthy HO,Hirst DG,Robson T
Sat Nov 01 00:00:00 EDT 2008
A novel FK506-like binding protein interacts with the glucocorticoid receptor and regulates steroid receptor signaling.
Endocrinology
McKeen HD,McAlpine K,Valentine A,Quinn DJ,McClelland K,Byrne C,O'Rourke M,Young S,Scott CJ,McCarthy HO,Hirst DG,Robson T
Sat Nov 01 00:00:00 EDT 2008
